Source: Pixabay.com
FDA Grants Breakthrough Therapy Designation to Investigational Hepatitis D Treatment
According to a press release from Eiger Biopharmaceuticals, the American Food and Drug Administration (FDA) recently granted the Company's experimental hepatitis delta virus drug (hepatitis D), peginterferon lambda, breakthrough therapy…
Continue Reading
FDA Grants Breakthrough Therapy Designation to Investigational Hepatitis D Treatment
